The Potential Implication of Immunogenetics in Cancer and Autoimmunity
Abstract
-
1. Rashid T, Mehraj A, Mushtaq NRasool S. Chapter 1 - Origin and history of immunogenetics. In: Rehman MU, Arafah A, Ali MN, Ali S, editors. A Molecular Approach to Immunogenetics: Academic Press; 2022. p. 1-19.
2. Burnet SFM. The clonal selection theory of acquired immunity: Vanderbilt University Press Nashville; 1959.
3. Sanchez-Mazas A, Fernandez-Viña M, Middleton D, Hollenbach JA, Buhler S, Di D, et al. Immunogenetics as a tool in anthropological studies. Immunology. 2011;133(2):143-64.
4. Heidari A, Sharif PMRezaei N. The association between tumor-associated macrophages and glioblastoma: a potential target for therapy. Current Pharmaceutical Design. 2021;27(46):4650-62.
5. Ladanyi ATimar J, editors. Immunologic and immunogenomic aspects of tumor progression. Seminars in Cancer Biology; 2020: Elsevier.
6. Hirbod-Mobarakeh A, Shabani M, Keshavarz-Fathi M, Delavari F, Amirzargar AA, Nikbin B, et al. Immunogenetics of Cancer. In: Rezaei N, editor. Cancer Immunology: A Translational Medicine Context. Cham: Springer International Publishing; 2020. p. 417-78.
7. Chen SS, Wu WZ, Zhang YPHuang WJ. Gene polymorphisms of SOCS1 and SOCS2 and acute lymphoblastic leukemia. Eur Rev Med Pharmacol Sci. 2020;24(10):5564-72.
8. Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, Schreiber RD, et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol. 2006;7(1):33-9.
9. Oksenberg JRBrassat D. Immunogenetics of autoimmune disease: Springer Science & Business Media; 2007.
10. Goris AListon A. The immunogenetic architecture of autoimmune disease. Cold Spring Harbor perspectives in biology. 2012;4(3):a007260.
11. Puglisi F, Capuano P, Simone M, Verzillo F, Laurentaci CCatalano G. Immunogenetics of inflammatory bowel disease. Minerva gastroenterologica e dietologica. 1999;45(1):5-9.
2. Burnet SFM. The clonal selection theory of acquired immunity: Vanderbilt University Press Nashville; 1959.
3. Sanchez-Mazas A, Fernandez-Viña M, Middleton D, Hollenbach JA, Buhler S, Di D, et al. Immunogenetics as a tool in anthropological studies. Immunology. 2011;133(2):143-64.
4. Heidari A, Sharif PMRezaei N. The association between tumor-associated macrophages and glioblastoma: a potential target for therapy. Current Pharmaceutical Design. 2021;27(46):4650-62.
5. Ladanyi ATimar J, editors. Immunologic and immunogenomic aspects of tumor progression. Seminars in Cancer Biology; 2020: Elsevier.
6. Hirbod-Mobarakeh A, Shabani M, Keshavarz-Fathi M, Delavari F, Amirzargar AA, Nikbin B, et al. Immunogenetics of Cancer. In: Rezaei N, editor. Cancer Immunology: A Translational Medicine Context. Cham: Springer International Publishing; 2020. p. 417-78.
7. Chen SS, Wu WZ, Zhang YPHuang WJ. Gene polymorphisms of SOCS1 and SOCS2 and acute lymphoblastic leukemia. Eur Rev Med Pharmacol Sci. 2020;24(10):5564-72.
8. Fenner JE, Starr R, Cornish AL, Zhang JG, Metcalf D, Schreiber RD, et al. Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity. Nat Immunol. 2006;7(1):33-9.
9. Oksenberg JRBrassat D. Immunogenetics of autoimmune disease: Springer Science & Business Media; 2007.
10. Goris AListon A. The immunogenetic architecture of autoimmune disease. Cold Spring Harbor perspectives in biology. 2012;4(3):a007260.
11. Puglisi F, Capuano P, Simone M, Verzillo F, Laurentaci CCatalano G. Immunogenetics of inflammatory bowel disease. Minerva gastroenterologica e dietologica. 1999;45(1):5-9.
| Files | ||
| Issue | Vol 5, No 2 (2022) | |
| Section | Editorial | |
| DOI | https://doi.org/10.18502/igj.v5i2.15095 | |
| Keywords | ||
| Immunogenetics | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Heidari A. The Potential Implication of Immunogenetics in Cancer and Autoimmunity. Immunol Genet J. 2022;5(2):66-68.
